This looks promising: an RNA-based vaccine effective against any strain of a virus and works for those with weakened immune system (babies, immunocompromised). “This could be the universal vaccine that we have been looking for.”
Advertise here with Carbon Ads
This site is made possible by member support. ❤️
Big thanks to Arcustech for hosting the site and offering amazing tech support.
When you buy through links on kottke.org, I may earn an affiliate commission. Thanks for supporting the site!
kottke.org. home of fine hypertext products since 1998.
Comments 3
I sure hope this lives up to the promise.
I wanted to note this is a university press release that links to a paper in a peer-reviewed, so grain of salt and all that. That's why I called it "promising" and not "amazing" or "a breakthrough".
The high-level concept is good - use RNA interference to fight viruses, rather than the adaptive immune system. I am not an immunologist but my sense is this is a dark-horse research program based on sound molecular biology principles.
The concept presented in the paper is an "attenuated virus" vaccine rather than an mRNA vaccine. They delete the viral gene, B2, that normally suppresses RNAi. Mice inoculated with live mutant virus then gets shredded by the RNAi pathway, and this provides lasting protection (siRNAs) against the non-mutant virus. The paper presents evidence that this works in mice with mutationally inactivated immune systems, providing evidence that viral suppression occurs via the RNAi system.
Antiviral RNAi has been known for a long time in insects and plants. I am not an immunologist so don't understand why the post-1998 boom in RNAi research did not result in this kind of advance, or if there are other practical barriers.
I was actually just looking for papers on this topic a few weeks ago for a class I'm teaching and had a hard time finding anything -- so thanks for posting this!
Hello! In order to comment or fave, you need to be a current kottke.org member. If you'd like to sign up for a membership to support the site and join the conversation, you can explore your options here.
Existing members can sign in here. If you're a former member, you can renew your membership.
Note: If you are a member and tried to log in, it didn't work, and now you're stuck in a neverending login loop of death, try disabling any ad blockers or extensions that you have installed on your browser...sometimes they can interfere with the Memberful links. Still having trouble? Email me!
In order to comment or fave, you need to be a current kottke.org member. Check out your options for renewal.
This is the name that'll be displayed next to comments you make on kottke.org; your email will not be displayed publicly. I'd encourage you to use your real name (or at least your first name and last initial) but you can also pick something that you go by when you participate in communities online. Choose something durable and reasonably unique (not "Me" or "anon"). Please don't change this often. No impersonation.
Note: I'm letting folks change their display names because the membership service that kottke.org uses collects full names and I thought some people might not want their names displayed publicly here. If it gets abused, I might disable this feature.
If you feel like this comment goes against the grain of the community guidelines or is otherwise inappropriate, please let me know and I will take a look at it.
Hello! In order to leave a comment, you need to be a current kottke.org member. If you'd like to sign up for a membership to support the site and join the conversation, you can explore your options here.
Existing members can sign in here. If you're a former member, you can renew your membership.
Note: If you are a member and tried to log in, it didn't work, and now you're stuck in a neverending login loop of death, try disabling any ad blockers or extensions that you have installed on your browser...sometimes they can interfere with the Memberful links. Still having trouble? Email me!